Filing Details

Accession Number:
0001209191-16-156543
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-12-22 16:48:40
Reporting Period:
2016-12-20
Filing Date:
2016-12-22
Accepted Time:
2016-12-22 16:48:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1510580 Kite Pharma Inc. KITE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222082 M Cynthia Butitta C/O Kite Pharma, Inc.
2225 Colorado Avenue
Santa Monica CA 90404
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-12-20 2,482 $50.86 92,995 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.